<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1994-06-01" modified="2017-05-10" version="201">
<accession>P36897</accession>
<accession>Q6IR47</accession>
<accession>Q706C0</accession>
<accession>Q706C1</accession>
<name>TGFR1_HUMAN</name>
<protein>
<recommendedName>
<fullName>TGF-beta receptor type-1</fullName>
<shortName>TGFR-1</shortName>
<ecNumber>2.7.11.30</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Activin A receptor type II-like protein kinase of 53kD</fullName>
</alternativeName>
<alternativeName>
<fullName>Activin receptor-like kinase 5</fullName>
<shortName>ALK-5</shortName>
<shortName>ALK5</shortName>
</alternativeName>
<alternativeName>
<fullName>Serine/threonine-protein kinase receptor R4</fullName>
<shortName>SKR4</shortName>
</alternativeName>
<alternativeName>
<fullName>TGF-beta type I receptor</fullName>
</alternativeName>
<alternativeName>
<fullName>Transforming growth factor-beta receptor type I</fullName>
<shortName>TGF-beta receptor type I</shortName>
<shortName>TbetaR-I</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">TGFBR1</name>
<name type="synonym">ALK5</name>
<name type="synonym">SKR4</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1993" name="Cell" volume="75" first="681" last="692">
<title>Cloning of a TGF beta type I receptor that forms a heteromeric complex with the TGF beta type II receptor.</title>
<authorList>
<person name="Franzen P."/>
<person name="ten Dijke P."/>
<person name="Ichijo H."/>
<person name="Yamashita H."/>
<person name="Schulz P."/>
<person name="Heldin C.-H."/>
<person name="Miyazono K."/>
</authorList>
<dbReference type="PubMed" id="8242743"/>
<dbReference type="DOI" id="10.1016/0092-8674(93)90489-D"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1997" name="Genomics" volume="46" first="278" last="283">
<title>Cloning and genomic organization of the human transforming growth factor-beta type I receptor gene.</title>
<authorList>
<person name="Vellucci V.F."/>
<person name="Reiss M."/>
</authorList>
<dbReference type="PubMed" id="9417915"/>
<dbReference type="DOI" id="10.1006/geno.1997.5023"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="3">
<citation type="submission" date="1997-11" db="EMBL/GenBank/DDBJ databases">
<title>The genomic structure of the gene encoding the human transforming growth factor beta type I receptor.</title>
<authorList>
<person name="Lynch M.A."/>
<person name="Song H."/>
<person name="DeGroff V.L."/>
<person name="Alam K.Y."/>
<person name="Adams E.M."/>
<person name="Weghorst C.M."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="4">
<citation type="submission" date="2003-12" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nature" volume="429" first="369" last="374">
<title>DNA sequence and analysis of human chromosome 9.</title>
<authorList>
<person name="Humphray S.J."/>
<person name="Oliver K."/>
<person name="Hunt A.R."/>
<person name="Plumb R.W."/>
<person name="Loveland J.E."/>
<person name="Howe K.L."/>
<person name="Andrews T.D."/>
<person name="Searle S."/>
<person name="Hunt S.E."/>
<person name="Scott C.E."/>
<person name="Jones M.C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Ashwell R.I.S."/>
<person name="Babbage A.K."/>
<person name="Babbage S."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Banerjee R."/>
<person name="Barker D.J."/>
<person name="Barlow K.F."/>
<person name="Bates K."/>
<person name="Beasley H."/>
<person name="Beasley O."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burford D."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Chen Y."/>
<person name="Clarke G."/>
<person name="Clark S.Y."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Crosier M."/>
<person name="Cummings A.T."/>
<person name="Davies J."/>
<person name="Dhami P."/>
<person name="Dunn M."/>
<person name="Dutta I."/>
<person name="Dyer L.W."/>
<person name="Earthrowl M.E."/>
<person name="Faulkner L."/>
<person name="Fleming C.J."/>
<person name="Frankish A."/>
<person name="Frankland J.A."/>
<person name="French L."/>
<person name="Fricker D.G."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Ghori J."/>
<person name="Gilbert J.G.R."/>
<person name="Glison C."/>
<person name="Grafham D.V."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Guy J."/>
<person name="Hall R.E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Harrison E.S.I."/>
<person name="Hart E.A."/>
<person name="Heath P.D."/>
<person name="Henderson C.D."/>
<person name="Hopkins B.L."/>
<person name="Howard P.J."/>
<person name="Howden P.J."/>
<person name="Huckle E."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A.A."/>
<person name="Kay M."/>
<person name="Keenan S."/>
<person name="Kershaw J.K."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A."/>
<person name="Laird G.K."/>
<person name="Langford C."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Leversha M."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Lovell J."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="McLaren S."/>
<person name="McLay K.E."/>
<person name="McMurray A."/>
<person name="Milne S."/>
<person name="Nickerson T."/>
<person name="Nisbett J."/>
<person name="Nordsiek G."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Porter K.M."/>
<person name="Pandian R."/>
<person name="Pelan S."/>
<person name="Phillimore B."/>
<person name="Povey S."/>
<person name="Ramsey Y."/>
<person name="Rand V."/>
<person name="Scharfe M."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Sims S.K."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C.A."/>
<person name="Swarbreck D."/>
<person name="Sycamore N."/>
<person name="Tester J."/>
<person name="Thorpe A."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Thomas D.W."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="West A.P."/>
<person name="Whitehead S.L."/>
<person name="Willey D.L."/>
<person name="Williams S.A."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Young L."/>
<person name="Ashurst J.L."/>
<person name="Coulson A."/>
<person name="Blocker H."/>
<person name="Durbin R.M."/>
<person name="Sulston J.E."/>
<person name="Hubbard T."/>
<person name="Jackson M.J."/>
<person name="Bentley D.R."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Dunham I."/>
</authorList>
<dbReference type="PubMed" id="15164053"/>
<dbReference type="DOI" id="10.1038/nature02465"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3)</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="1998" name="Cancer Res." volume="58" first="2727" last="2732">
<title>Type I transforming growth factor beta receptor maps to 9q22 and exhibits a polymorphism and a rare variant within a polyalanine tract.</title>
<authorList>
<person name="Pasche B."/>
<person name="Luo Y."/>
<person name="Rao P.H."/>
<person name="Nimer S.D."/>
<person name="Dmitrovsky E."/>
<person name="Caron P."/>
<person name="Luzzatto L."/>
<person name="Offit K."/>
<person name="Cordon-Cardo C."/>
<person name="Renault B."/>
<person name="Satagopan J.M."/>
<person name="Murty V.V."/>
<person name="Massague J."/>
</authorList>
<dbReference type="PubMed" id="9661882"/>
</citation>
<scope>PROTEIN SEQUENCE OF 34-40</scope>
<scope>SIGNAL SEQUENCE CLEAVAGE SITE</scope>
<scope>GLYCOSYLATION</scope>
<scope>CHARACTERIZATION OF VARIANT TGFBR1*6A ALA-24--26-ALA DEL</scope>
<scope>VARIANT TGFBR1*10A ALA-26 INS</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2007" name="BMC Genomics" volume="8" first="318" last="318">
<title>Alternative splicing of TGF-betas and their high-affinity receptors T beta RI, T beta RII and T beta RIII (betaglycan) reveal new variants in human prostatic cells.</title>
<authorList>
<person name="Konrad L."/>
<person name="Scheiber J.A."/>
<person name="Volck-Badouin E."/>
<person name="Keilani M.M."/>
<person name="Laible L."/>
<person name="Brandt H."/>
<person name="Schmidt A."/>
<person name="Aumuller G."/>
<person name="Hofmann R."/>
</authorList>
<dbReference type="PubMed" id="17845732"/>
<dbReference type="DOI" id="10.1186/1471-2164-8-318"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 61-155 (ISOFORM 1)</scope>
<scope>ALTERNATIVE SPLICING</scope>
<source>
<tissue>Prostate</tissue>
</source>
</reference>
<reference key="9">
<citation type="submission" date="2011-03" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Konrad L."/>
</authorList>
</citation>
<scope>SEQUENCE REVISION (ISOFORM 1)</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1995" name="EMBO J." volume="14" first="2199" last="2208">
<title>GS domain mutations that constitutively activate T beta R-I, the downstream signaling component in the TGF-beta receptor complex.</title>
<authorList>
<person name="Wieser R."/>
<person name="Wrana J.L."/>
<person name="Massague J."/>
</authorList>
<dbReference type="PubMed" id="7774578"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION AT THR-185; THR-186; SER-187; SER-189 AND SER-191 BY TGFBR2</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>SUBUNIT</scope>
<scope>MUTAGENESIS OF 185-THR-THR-186; SER-187; SER-189; SER-191; THR-200 AND THR-204</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1996" name="Cell" volume="86" first="543" last="552">
<title>MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma.</title>
<authorList>
<person name="Eppert K."/>
<person name="Scherer S.W."/>
<person name="Ozcelik H."/>
<person name="Pirone R."/>
<person name="Hoodless P."/>
<person name="Kim H."/>
<person name="Tsui L.-C."/>
<person name="Bapat B."/>
<person name="Gallinger S."/>
<person name="Andrulis I.L."/>
<person name="Thomsen G.H."/>
<person name="Wrana J.L."/>
<person name="Attisano L."/>
</authorList>
<dbReference type="PubMed" id="8752209"/>
<dbReference type="DOI" id="10.1016/S0092-8674(00)80128-2"/>
</citation>
<scope>FUNCTION IN PHOSPHORYLATION OF SMAD2</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1996" name="Cell" volume="87" first="1215" last="1224">
<title>MADR2 is a substrate of the TGFbeta receptor and its phosphorylation is required for nuclear accumulation and signaling.</title>
<authorList>
<person name="Macias-Silva M."/>
<person name="Abdollah S."/>
<person name="Hoodless P.A."/>
<person name="Pirone R."/>
<person name="Attisano L."/>
<person name="Wrana J.L."/>
</authorList>
<dbReference type="PubMed" id="8980228"/>
<dbReference type="DOI" id="10.1016/S0092-8674(00)81817-6"/>
</citation>
<scope>INTERACTION WITH SMAD2</scope>
<scope>FUNCTION IN PHOSPHORYLATION OF SMAD2</scope>
<scope>FUNCTION IN TRANSCRIPTION REGULATION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1997" name="EMBO J." volume="16" first="3866" last="3876">
<title>Mechanism of TGFbeta receptor inhibition by FKBP12.</title>
<authorList>
<person name="Chen Y.G."/>
<person name="Liu F."/>
<person name="Massague J."/>
</authorList>
<dbReference type="PubMed" id="9233797"/>
<dbReference type="DOI" id="10.1093/emboj/16.13.3866"/>
</citation>
<scope>INTERACTION WITH FKBP1A</scope>
<scope>ENZYME REGULATION</scope>
<scope>MUTAGENESIS OF LEU-193 AND PRO-194</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1997" name="EMBO J." volume="16" first="5353" last="5362">
<title>TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.</title>
<authorList>
<person name="Nakao A."/>
<person name="Imamura T."/>
<person name="Souchelnytskyi S."/>
<person name="Kawabata M."/>
<person name="Ishisaki A."/>
<person name="Oeda E."/>
<person name="Tamaki K."/>
<person name="Hanai J."/>
<person name="Heldin C.H."/>
<person name="Miyazono K."/>
<person name="ten Dijke P."/>
</authorList>
<dbReference type="PubMed" id="9311995"/>
<dbReference type="DOI" id="10.1093/emboj/16.17.5353"/>
</citation>
<scope>INTERACTION WITH SMAD3</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1997" name="J. Biol. Chem." volume="272" first="27678" last="27685">
<title>TbetaRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling.</title>
<authorList>
<person name="Abdollah S."/>
<person name="Macias-Silva M."/>
<person name="Tsukazaki T."/>
<person name="Hayashi H."/>
<person name="Attisano L."/>
<person name="Wrana J.L."/>
</authorList>
<dbReference type="PubMed" id="9346908"/>
<dbReference type="DOI" id="10.1074/jbc.272.44.27678"/>
</citation>
<scope>INTERACTION WITH SMAD2</scope>
<scope>FUNCTION IN PHOSPHORYLATION OF SMAD2</scope>
<scope>FUNCTION IN TRANSCRIPTION REGULATION</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1998" name="Cell" volume="95" first="779" last="791">
<title>SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor.</title>
<authorList>
<person name="Tsukazaki T."/>
<person name="Chiang T.A."/>
<person name="Davison A.F."/>
<person name="Attisano L."/>
<person name="Wrana J.L."/>
</authorList>
<dbReference type="PubMed" id="9865696"/>
<dbReference type="DOI" id="10.1016/S0092-8674(00)81701-8"/>
</citation>
<scope>INTERACTION WITH ZFYVE9</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1998" name="J. Cell Biol." volume="140" first="767" last="777">
<title>Oligomeric structure of type I and type II transforming growth factor beta receptors: homodimers form in the ER and persist at the plasma membrane.</title>
<authorList>
<person name="Gilboa L."/>
<person name="Wells R.G."/>
<person name="Lodish H.F."/>
<person name="Henis Y.I."/>
</authorList>
<dbReference type="PubMed" id="9472030"/>
<dbReference type="DOI" id="10.1083/jcb.140.4.767"/>
</citation>
<scope>HOMODIMERIZATION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2000" name="Mol. Cell" volume="6" first="1365" last="1375">
<title>Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF-beta receptor for degradation.</title>
<authorList>
<person name="Kavsak P."/>
<person name="Rasmussen R.K."/>
<person name="Causing C.G."/>
<person name="Bonni S."/>
<person name="Zhu H."/>
<person name="Thomsen G.H."/>
<person name="Wrana J.L."/>
</authorList>
<dbReference type="PubMed" id="11163210"/>
<dbReference type="DOI" id="10.1016/S1097-2765(00)00134-9"/>
</citation>
<scope>INTERACTION WITH SMAD7 AND SMURF2</scope>
<scope>PROTEASOMAL AND LYSOSOMAL DEGRADATION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="12477" last="12480">
<title>Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation.</title>
<authorList>
<person name="Ebisawa T."/>
<person name="Fukuchi M."/>
<person name="Murakami G."/>
<person name="Chiba T."/>
<person name="Tanaka K."/>
<person name="Imamura T."/>
<person name="Miyazono K."/>
</authorList>
<dbReference type="PubMed" id="11278251"/>
<dbReference type="DOI" id="10.1074/jbc.C100008200"/>
</citation>
<scope>INTERACTION WITH SMAD7 AND SMURF1</scope>
<scope>PROTEASOMAL DEGRADATION</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2003" name="EMBO J." volume="22" first="4465" last="4477">
<title>TLP, a novel modulator of TGF-beta signaling, has opposite effects on Smad2- and Smad3-dependent signaling.</title>
<authorList>
<person name="Felici A."/>
<person name="Wurthner J.U."/>
<person name="Parks W.T."/>
<person name="Giam L.R."/>
<person name="Reiss M."/>
<person name="Karpova T.S."/>
<person name="McNally J.G."/>
<person name="Roberts A.B."/>
</authorList>
<dbReference type="PubMed" id="12941698"/>
<dbReference type="DOI" id="10.1093/emboj/cdg428"/>
</citation>
<scope>INTERACTION WITH VPS39</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2005" name="Biochem. J." volume="386" first="461" last="470">
<title>NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.</title>
<authorList>
<person name="Kuratomi G."/>
<person name="Komuro A."/>
<person name="Goto K."/>
<person name="Shinozaki M."/>
<person name="Miyazawa K."/>
<person name="Miyazono K."/>
<person name="Imamura T."/>
</authorList>
<dbReference type="PubMed" id="15496141"/>
<dbReference type="DOI" id="10.1042/BJ20040738"/>
</citation>
<scope>INTERACTION WITH NEDD4L</scope>
<scope>UBIQUITINATION</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2005" name="Science" volume="307" first="1603" last="1609">
<title>Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity.</title>
<authorList>
<person name="Ozdamar B."/>
<person name="Bose R."/>
<person name="Barrios-Rodiles M."/>
<person name="Wang H.R."/>
<person name="Zhang Y."/>
<person name="Wrana J.L."/>
</authorList>
<dbReference type="PubMed" id="15761148"/>
<dbReference type="DOI" id="10.1126/science.1105718"/>
</citation>
<scope>FUNCTION IN EPITHELIAL TO MESENCHYMAL TRANSITION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH PARD6A</scope>
<scope>FUNCTION IN PHOSPHORYLATION OF PARD6A</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2006" name="FASEB J." volume="20" first="1525" last="1527">
<title>Identification of CD109 as part of the TGF-beta receptor system in human keratinocytes.</title>
<authorList>
<person name="Finnson K.W."/>
<person name="Tam B.Y.Y."/>
<person name="Liu K."/>
<person name="Marcoux A."/>
<person name="Lepage P."/>
<person name="Roy S."/>
<person name="Bizet A.A."/>
<person name="Philip A."/>
</authorList>
<dbReference type="PubMed" id="16754747"/>
<dbReference type="DOI" id="10.1096/fj.05-5229fje"/>
</citation>
<scope>FUNCTION IN CELLULAR GROWTH INHIBITION</scope>
<scope>INTERACTION WITH CD109</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2006" name="Nucleic Acids Res." volume="34" first="6314" last="6326">
<title>Potentiation of Smad-mediated transcriptional activation by the RNA-binding protein RBPMS.</title>
<authorList>
<person name="Sun Y."/>
<person name="Ding L."/>
<person name="Zhang H."/>
<person name="Han J."/>
<person name="Yang X."/>
<person name="Yan J."/>
<person name="Zhu Y."/>
<person name="Li J."/>
<person name="Song H."/>
<person name="Ye Q."/>
</authorList>
<dbReference type="PubMed" id="17099224"/>
<dbReference type="DOI" id="10.1093/nar/gkl914"/>
</citation>
<scope>INTERACTION WITH RBPMS</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2008" name="Nat. Cell Biol." volume="10" first="1199" last="1207">
<title>The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner.</title>
<authorList>
<person name="Sorrentino A."/>
<person name="Thakur N."/>
<person name="Grimsby S."/>
<person name="Marcusson A."/>
<person name="von Bulow V."/>
<person name="Schuster N."/>
<person name="Zhang S."/>
<person name="Heldin C.H."/>
<person name="Landstrom M."/>
</authorList>
<dbReference type="PubMed" id="18758450"/>
<dbReference type="DOI" id="10.1038/ncb1780"/>
</citation>
<scope>FUNCTION IN APOPTOSIS</scope>
<scope>INTERACTION WITH TRAF6 AND MAP3K7</scope>
</reference>
<reference key="26">
<citation type="journal article" date="1998" name="Annu. Rev. Biochem." volume="67" first="753" last="791">
<title>TGF-beta signal transduction.</title>
<authorList>
<person name="Massague J."/>
</authorList>
<dbReference type="PubMed" id="9759503"/>
<dbReference type="DOI" id="10.1146/annurev.biochem.67.1.753"/>
</citation>
<scope>REVIEW ON PROCESSES REGULATED BY THE TGF-BETA CYTOKINES</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2009" name="Mol. Cell. Proteomics" volume="8" first="1751" last="1764">
<title>Large-scale proteomics analysis of the human kinome.</title>
<authorList>
<person name="Oppermann F.S."/>
<person name="Gnad F."/>
<person name="Olsen J.V."/>
<person name="Hornberger R."/>
<person name="Greff Z."/>
<person name="Keri G."/>
<person name="Mann M."/>
<person name="Daub H."/>
</authorList>
<dbReference type="PubMed" id="19369195"/>
<dbReference type="DOI" id="10.1074/mcp.M800588-MCP200"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-165</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2012" name="Nat. Med." volume="18" first="429" last="435">
<title>USP15 stabilizes TGF-beta receptor I and promotes oncogenesis through the activation of TGF-beta signaling in glioblastoma.</title>
<authorList>
<person name="Eichhorn P.J."/>
<person name="Rodon L."/>
<person name="Gonzalez-Junca A."/>
<person name="Dirac A."/>
<person name="Gili M."/>
<person name="Martinez-Saez E."/>
<person name="Aura C."/>
<person name="Barba I."/>
<person name="Peg V."/>
<person name="Prat A."/>
<person name="Cuartas I."/>
<person name="Jimenez J."/>
<person name="Garcia-Dorado D."/>
<person name="Sahuquillo J."/>
<person name="Bernards R."/>
<person name="Baselga J."/>
<person name="Seoane J."/>
</authorList>
<dbReference type="PubMed" id="22344298"/>
<dbReference type="DOI" id="10.1038/nm.2619"/>
</citation>
<scope>UBIQUITINATION</scope>
<scope>DEUBIQUITINATION BY USP15</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2016" name="Oncogene" volume="35" first="389" last="401">
<title>Syntenin regulates TGF-beta1-induced Smad activation and the epithelial-to-mesenchymal transition by inhibiting caveolin-mediated TGF-beta type I receptor internalization.</title>
<authorList>
<person name="Hwangbo C."/>
<person name="Tae N."/>
<person name="Lee S."/>
<person name="Kim O."/>
<person name="Park O.K."/>
<person name="Kim J."/>
<person name="Kwon S.H."/>
<person name="Lee J.H."/>
</authorList>
<dbReference type="PubMed" id="25893292"/>
<dbReference type="DOI" id="10.1038/onc.2015.100"/>
</citation>
<scope>INTERACTION WITH SDCBP AND CAV1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>UBIQUITINATION</scope>
<scope>PROTEASOMAL DEGRADATION</scope>
</reference>
<reference key="30">
<citation type="journal article" date="1995" name="FEBS Lett." volume="376" first="31" last="36">
<title>Extracellular domain of type I receptor for transforming growth factor-beta: molecular modelling using protectin (CD59) as a template.</title>
<authorList>
<person name="Jokiranta T.S."/>
<person name="Tissari J."/>
<person name="Teleman O."/>
<person name="Meri S."/>
</authorList>
<dbReference type="PubMed" id="8521960"/>
<dbReference type="DOI" id="10.1016/0014-5793(95)01239-7"/>
</citation>
<scope>3D-STRUCTURE MODELING OF 34-114</scope>
</reference>
<reference key="31">
<citation type="journal article" date="1999" name="Cell" volume="96" first="425" last="436">
<title>Crystal structure of the cytoplasmic domain of the type I TGF beta receptor in complex with FKBP12.</title>
<authorList>
<person name="Huse M."/>
<person name="Chen Y.-G."/>
<person name="Massague J."/>
<person name="Kuriyan J."/>
</authorList>
<dbReference type="PubMed" id="10025408"/>
<dbReference type="DOI" id="10.1016/S0092-8674(00)80555-3"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 162-503 IN COMPLEX WITH FKBP1A</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2001" name="Mol. Cell" volume="8" first="671" last="682">
<title>The TGF beta receptor activation process: an inhibitor- to substrate-binding switch.</title>
<authorList>
<person name="Huse M."/>
<person name="Muir T.W."/>
<person name="Xu L."/>
<person name="Chen Y.-G."/>
<person name="Kuriyan J."/>
<person name="Massague J."/>
</authorList>
<dbReference type="PubMed" id="11583628"/>
<dbReference type="DOI" id="10.1016/S1097-2765(01)00332-X"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 162-503</scope>
<scope>PHOSPHORYLATION</scope>
<scope>INTERACTION WITH SMAD2 AND FKBP1A</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2004" name="Bioorg. Med. Chem. Lett." volume="14" first="3581" last="3584">
<title>Synthesis and activity of new aryl- and heteroaryl-substituted 5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole inhibitors of the transforming growth factor-beta type I receptor kinase domain.</title>
<authorList>
<person name="Sawyer J.S."/>
<person name="Beight D.W."/>
<person name="Britt K.S."/>
<person name="Anderson B.D."/>
<person name="Campbell R.M."/>
<person name="Goodson T. Jr."/>
<person name="Herron D.K."/>
<person name="Li H.-Y."/>
<person name="McMillen W.T."/>
<person name="Mort N."/>
<person name="Parsons S."/>
<person name="Smith E.C.R."/>
<person name="Wagner J.R."/>
<person name="Yan L."/>
<person name="Zhang F."/>
<person name="Yingling J.M."/>
</authorList>
<dbReference type="PubMed" id="15177479"/>
<dbReference type="DOI" id="10.1016/j.bmcl.2004.04.007"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 175-500 IN COMPLEX WITH SYNTHETIC INHIBITOR</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2004" name="J. Med. Chem." volume="47" first="4494" last="4506">
<title>Identification of 1,5-naphthyridine derivatives as a novel series of potent and selective TGF-beta type I receptor inhibitors.</title>
<authorList>
<person name="Gellibert F."/>
<person name="Woolven J."/>
<person name="Fouchet M.-H."/>
<person name="Mathews N."/>
<person name="Goodland H."/>
<person name="Lovegrove V."/>
<person name="Laroze A."/>
<person name="Nguyen V.-L."/>
<person name="Sautet S."/>
<person name="Wang R."/>
<person name="Janson C."/>
<person name="Smith W."/>
<person name="Krysa G."/>
<person name="Boullay V."/>
<person name="De Gouville A.-C."/>
<person name="Huet S."/>
<person name="Hartley D."/>
</authorList>
<dbReference type="PubMed" id="15317461"/>
<dbReference type="DOI" id="10.1021/jm0400247"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 201-503 IN COMPLEX WITH SYNTHETIC INHIBITOR</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2008" name="Mol. Cell" volume="29" first="157" last="168">
<title>Cooperative assembly of TGF-beta superfamily signaling complexes is mediated by two disparate mechanisms and distinct modes of receptor binding.</title>
<authorList>
<person name="Groppe J."/>
<person name="Hinck C.S."/>
<person name="Samavarchi-Tehrani P."/>
<person name="Zubieta C."/>
<person name="Schuermann J.P."/>
<person name="Taylor A.B."/>
<person name="Schwarz P.M."/>
<person name="Wrana J.L."/>
<person name="Hinck A.P."/>
</authorList>
<dbReference type="PubMed" id="18243111"/>
<dbReference type="DOI" id="10.1016/j.molcel.2007.11.039"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.00 ANGSTROMS) OF 33-111 IN COMPLEX WITH TGFBR2 AND TGFB3</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="14806" last="14814">
<title>Ternary complex of transforming growth factor-beta1 reveals isoform-specific ligand recognition and receptor recruitment in the superfamily.</title>
<authorList>
<person name="Radaev S."/>
<person name="Zou Z."/>
<person name="Huang T."/>
<person name="Lafer E.M."/>
<person name="Hinck A.P."/>
<person name="Sun P.D."/>
</authorList>
<dbReference type="PubMed" id="20207738"/>
<dbReference type="DOI" id="10.1074/jbc.M109.079921"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.00 ANGSTROMS) OF 31-115 IN COMPLEX WITH TGFBR2 AND TGFB1</scope>
<scope>RECEPTOR AFFINITY FOR LIGANDS</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2003" name="J. Clin. Oncol." volume="21" first="3236" last="3243">
<title>TGFBR1*6A and cancer risk: a meta-analysis of seven case-control studies.</title>
<authorList>
<person name="Kaklamani V.G."/>
<person name="Hou N."/>
<person name="Bian Y."/>
<person name="Reich J."/>
<person name="Offit K."/>
<person name="Michel L.S."/>
<person name="Rubinstein W.S."/>
<person name="Rademaker A."/>
<person name="Pasche B."/>
</authorList>
<dbReference type="PubMed" id="12947057"/>
<dbReference type="DOI" id="10.1200/JCO.2003.11.524"/>
</citation>
<scope>ANALYSIS OF VARIANT TGFBR1*6A ALA-24--26-ALA DEL IN CANCER RISK</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2004" name="BMC Genet." volume="5" first="28" last="28">
<title>No major association between TGFBR1*6A and prostate cancer.</title>
<authorList>
<person name="Kaklamani V.G."/>
<person name="Baddi L."/>
<person name="Rosman D."/>
<person name="Liu J."/>
<person name="Ellis N."/>
<person name="Oddoux C."/>
<person name="Ostrer H."/>
<person name="Chen Y."/>
<person name="Ahsan H."/>
<person name="Offit K."/>
<person name="Pasche B."/>
</authorList>
<dbReference type="PubMed" id="15385056"/>
<dbReference type="DOI" id="10.1186/1471-2156-5-28"/>
</citation>
<scope>ANALYSIS OF VARIANT TGFBR1*6A ALA-24--26-ALA DEL IN PROSTATE CANCER</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2005" name="Nat. Genet." volume="37" first="275" last="281">
<title>A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2.</title>
<authorList>
<person name="Loeys B.L."/>
<person name="Chen J."/>
<person name="Neptune E.R."/>
<person name="Judge D.P."/>
<person name="Podowski M."/>
<person name="Holm T."/>
<person name="Meyers J."/>
<person name="Leitch C.C."/>
<person name="Katsanis N."/>
<person name="Sharifi N."/>
<person name="Xu F.L."/>
<person name="Myers L.A."/>
<person name="Spevak P.J."/>
<person name="Cameron D.E."/>
<person name="De Backer J.F."/>
<person name="Hellemans J."/>
<person name="Chen Y."/>
<person name="Davis E.C."/>
<person name="Webb C.L."/>
<person name="Kress W."/>
<person name="Coucke P.J."/>
<person name="Rifkin D.B."/>
<person name="De Paepe A.M."/>
<person name="Dietz H.C."/>
</authorList>
<dbReference type="PubMed" id="15731757"/>
<dbReference type="DOI" id="10.1038/ng1511"/>
</citation>
<scope>VARIANTS LDS1 ILE-200; ARG-318; GLY-400 AND PRO-487</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2005" name="Prostate Cancer Prostatic Dis." volume="8" first="50" last="53">
<title>TGFBR1(*)6A is not associated with prostate cancer in men of European ancestry.</title>
<authorList>
<person name="Suarez B.K."/>
<person name="Pal P."/>
<person name="Jin C.H."/>
<person name="Kaushal R."/>
<person name="Sun G."/>
<person name="Jin L."/>
<person name="Pasche B."/>
<person name="Deka R."/>
<person name="Catalona W.J."/>
</authorList>
<dbReference type="PubMed" id="15505640"/>
<dbReference type="DOI" id="10.1038/sj.pcan.4500765"/>
</citation>
<scope>ANALYSIS OF VARIANT TGFBR1*6A ALA-24--26-ALA DEL IN PROSTATE CANCER</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2006" name="Am. J. Med. Genet. A" volume="140" first="1047" last="1058">
<title>FBN1, TGFBR1, and the Marfan-craniosynostosis/mental retardation disorders revisited.</title>
<authorList>
<person name="Ades L.C."/>
<person name="Sullivan K."/>
<person name="Biggin A."/>
<person name="Haan E.A."/>
<person name="Brett M."/>
<person name="Holman K.J."/>
<person name="Dixon J."/>
<person name="Robertson S."/>
<person name="Holmes A.D."/>
<person name="Rogers J."/>
<person name="Bennetts B."/>
</authorList>
<dbReference type="PubMed" id="16596670"/>
<dbReference type="DOI" id="10.1002/ajmg.a.31202"/>
</citation>
<scope>VARIANT LDS1 LEU-241</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2006" name="Hum. Mutat." volume="27" first="760" last="769">
<title>Identification and in silico analyses of novel TGFBR1 and TGFBR2 mutations in Marfan syndrome-related disorders.</title>
<authorList>
<person name="Matyas G."/>
<person name="Arnold E."/>
<person name="Carrel T."/>
<person name="Baumgartner D."/>
<person name="Boileau C."/>
<person name="Berger W."/>
<person name="Steinmann B."/>
</authorList>
<dbReference type="PubMed" id="16791849"/>
<dbReference type="DOI" id="10.1002/humu.20353"/>
</citation>
<scope>VARIANTS LDS1 LEU-241 AND GLN-487</scope>
<scope>VARIANT HIS-267</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2006" name="N. Engl. J. Med." volume="355" first="788" last="798">
<title>Aneurysm syndromes caused by mutations in the TGF-beta receptor.</title>
<authorList>
<person name="Loeys B.L."/>
<person name="Schwarze U."/>
<person name="Holm T."/>
<person name="Callewaert B.L."/>
<person name="Thomas G.H."/>
<person name="Pannu H."/>
<person name="De Backer J.F."/>
<person name="Oswald G.L."/>
<person name="Symoens S."/>
<person name="Manouvrier S."/>
<person name="Roberts A.E."/>
<person name="Faravelli F."/>
<person name="Greco M.A."/>
<person name="Pyeritz R.E."/>
<person name="Milewicz D.M."/>
<person name="Coucke P.J."/>
<person name="Cameron D.E."/>
<person name="Braverman A.C."/>
<person name="Byers P.H."/>
<person name="De Paepe A.M."/>
<person name="Dietz H.C."/>
</authorList>
<dbReference type="PubMed" id="16928994"/>
<dbReference type="DOI" id="10.1056/NEJMoa055695"/>
</citation>
<scope>VARIANTS LDS1 GLU-232; TRP-487; PRO-487 AND GLN-487</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] ILE-153 AND CYS-291</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2008" name="Nature" volume="456" first="66" last="72">
<title>DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome.</title>
<authorList>
<person name="Ley T.J."/>
<person name="Mardis E.R."/>
<person name="Ding L."/>
<person name="Fulton B."/>
<person name="McLellan M.D."/>
<person name="Chen K."/>
<person name="Dooling D."/>
<person name="Dunford-Shore B.H."/>
<person name="McGrath S."/>
<person name="Hickenbotham M."/>
<person name="Cook L."/>
<person name="Abbott R."/>
<person name="Larson D.E."/>
<person name="Koboldt D.C."/>
<person name="Pohl C."/>
<person name="Smith S."/>
<person name="Hawkins A."/>
<person name="Abbott S."/>
<person name="Locke D."/>
<person name="Hillier L.W."/>
<person name="Miner T."/>
<person name="Fulton L."/>
<person name="Magrini V."/>
<person name="Wylie T."/>
<person name="Glasscock J."/>
<person name="Conyers J."/>
<person name="Sander N."/>
<person name="Shi X."/>
<person name="Osborne J.R."/>
<person name="Minx P."/>
<person name="Gordon D."/>
<person name="Chinwalla A."/>
<person name="Zhao Y."/>
<person name="Ries R.E."/>
<person name="Payton J.E."/>
<person name="Westervelt P."/>
<person name="Tomasson M.H."/>
<person name="Watson M."/>
<person name="Baty J."/>
<person name="Ivanovich J."/>
<person name="Heath S."/>
<person name="Shannon W.D."/>
<person name="Nagarajan R."/>
<person name="Walter M.J."/>
<person name="Link D.C."/>
<person name="Graubert T.A."/>
<person name="DiPersio J.F."/>
<person name="Wilson R.K."/>
</authorList>
<dbReference type="PubMed" id="18987736"/>
<dbReference type="DOI" id="10.1038/nature07485"/>
</citation>
<scope>VARIANT [LARGE SCALE ANALYSIS] VAL-139</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2009" name="Orphanet J. Rare Dis." volume="4" first="24" last="24">
<title>Loeys-Dietz syndrome type I and type II: clinical findings and novel mutations in two Italian patients.</title>
<authorList>
<person name="Drera B."/>
<person name="Ritelli M."/>
<person name="Zoppi N."/>
<person name="Wischmeijer A."/>
<person name="Gnoli M."/>
<person name="Fattori R."/>
<person name="Calzavara-Pinton P.G."/>
<person name="Barlati S."/>
<person name="Colombi M."/>
</authorList>
<dbReference type="PubMed" id="19883511"/>
<dbReference type="DOI" id="10.1186/1750-1172-4-24"/>
</citation>
<scope>VARIANT LDS1 GLY-351</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2012" name="J. Hum. Genet." volume="57" first="52" last="56">
<title>Clinical features and genetic analysis of Korean patients with Loeys-Dietz syndrome.</title>
<authorList>
<person name="Yang J.H."/>
<person name="Ki C.S."/>
<person name="Han H."/>
<person name="Song B.G."/>
<person name="Jang S.Y."/>
<person name="Chung T.Y."/>
<person name="Sung K."/>
<person name="Lee H.J."/>
<person name="Kim D.K."/>
</authorList>
<dbReference type="PubMed" id="22113417"/>
<dbReference type="DOI" id="10.1038/jhg.2011.130"/>
</citation>
<scope>VARIANTS LDS1 TYR-266; ARG-375 AND GLN-487</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2012" name="J. Hum. Genet." volume="57" first="398" last="398">
<authorList>
<person name="Yang J.H."/>
<person name="Ki C.S."/>
<person name="Han H."/>
<person name="Song B.G."/>
<person name="Jang S.Y."/>
<person name="Chung T.Y."/>
<person name="Sung K."/>
<person name="Lee H.J."/>
<person name="Kim D.K."/>
</authorList>
</citation>
<scope>ERRATUM</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2011" name="Nat. Genet." volume="43" first="365" last="369">
<title>Multiple self-healing squamous epithelioma is caused by a disease-specific spectrum of mutations in TGFBR1.</title>
<authorList>
<person name="Goudie D.R."/>
<person name="D'Alessandro M."/>
<person name="Merriman B."/>
<person name="Lee H."/>
<person name="Szeverenyi I."/>
<person name="Avery S."/>
<person name="O'Connor B.D."/>
<person name="Nelson S.F."/>
<person name="Coats S.E."/>
<person name="Stewart A."/>
<person name="Christie L."/>
<person name="Pichert G."/>
<person name="Friedel J."/>
<person name="Hayes I."/>
<person name="Burrows N."/>
<person name="Whittaker S."/>
<person name="Gerdes A.M."/>
<person name="Broesby-Olsen S."/>
<person name="Ferguson-Smith M.A."/>
<person name="Verma C."/>
<person name="Lunny D.P."/>
<person name="Reversade B."/>
<person name="Lane E.B."/>
</authorList>
<dbReference type="PubMed" id="21358634"/>
<dbReference type="DOI" id="10.1038/ng.780"/>
</citation>
<scope>VARIANTS MSSE TYR-41; SER-45; ARG-52 AND LEU-83</scope>
</reference>
<comment type="function">
<text evidence="24 26 32 40 41 42 45">Transmembrane serine/threonine kinase forming with the TGF-beta type II serine/threonine kinase receptor, TGFBR2, the non-promiscuous receptor for the TGF-beta cytokines TGFB1, TGFB2 and TGFB3. Transduces the TGFB1, TGFB2 and TGFB3 signal from the cell surface to the cytoplasm and is thus regulating a plethora of physiological and pathological processes including cell cycle arrest in epithelial and hematopoietic cells, control of mesenchymal cell proliferation and differentiation, wound healing, extracellular matrix production, immunosuppression and carcinogenesis. The formation of the receptor complex composed of 2 TGFBR1 and 2 TGFBR2 molecules symmetrically bound to the cytokine dimer results in the phosphorylation and the activation of TGFBR1 by the constitutively active TGFBR2. Activated TGFBR1 phosphorylates SMAD2 which dissociates from the receptor and interacts with SMAD4. The SMAD2-SMAD4 complex is subsequently translocated to the nucleus where it modulates the transcription of the TGF-beta-regulated genes. This constitutes the canonical SMAD-dependent TGF-beta signaling cascade. Also involved in non-canonical, SMAD-independent TGF-beta signaling pathways. For instance, TGFBR1 induces TRAF6 autoubiquitination which in turn results in MAP3K7 ubiquitination and activation to trigger apoptosis. Also regulates epithelial to mesenchymal transition through a SMAD-independent signaling pathway through PARD6A phosphorylation and activation.</text>
</comment>
<comment type="catalytic activity">
<text>ATP + [receptor-protein] = ADP + [receptor-protein] phosphate.</text>
</comment>
<comment type="cofactor">
<cofactor evidence="10">
<name>Mg(2+)</name>
<dbReference type="ChEBI" id="CHEBI:18420"/>
</cofactor>
<cofactor evidence="10">
<name>Mn(2+)</name>
<dbReference type="ChEBI" id="CHEBI:29035"/>
</cofactor>
</comment>
<comment type="enzyme regulation">
<text evidence="43">Kept in an inactive conformation by FKBP1A preventing receptor activation in absence of ligand. CD109 is another inhibitor of the receptor.</text>
</comment>
<comment type="subunit">
<text evidence="15 16 17 18 19 20 21 22 24 26 29 31 32 35 39 40 42 43 44 45 48">Homodimer; in the endoplasmic reticulum but also at the cell membrane. Heterohexamer; TGFB1, TGFB2 and TGFB3 homodimeric ligands assemble a functional receptor composed of two TGFBR1 and TGFBR2 heterodimers to form a ligand-receptor heterohexamer. The respective affinity of TGBRB1 and TGFBR2 for the ligands may modulate the kinetics of assembly of the receptor and may explain the different biological activities of TGFB1, TGFB2 and TGFB3. Interacts with CD109; inhibits TGF-beta receptor activation in keratinocytes. Interacts with RBPMS. Interacts (unphosphorylated) with FKBP1A; prevents TGFBR1 phosphorylation by TGFBR2 and stabilizes it in the inactive conformation. Interacts with SMAD2, SMAD3 and ZFYVE9; ZFYVE9 recruits SMAD2 and SMAD3 to the TGF-beta receptor. Interacts with TRAF6 and MAP3K7; induces MAP3K7 activation by TRAF6. Interacts with PARD6A; involved in TGF-beta induced epithelial to mesenchymal transition. Interacts with SMAD7, NEDD4L, SMURF1 and SMURF2; SMAD7 recruits NEDD4L, SMURF1 and SMURF2 to the TGF-beta receptor. Interacts with USP15 and VPS39. Interacts with SDCBP (via C-terminus) (PubMed:25893292) Interacts with CAV1 and this interaction is impaired in the presence of SDCBP (PubMed:25893292).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1027557"/>
<interactant intactId="EBI-6858501">
<id>Q99IB8</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1027557"/>
<interactant intactId="EBI-1027571">
<id>P62942</id>
<label>FKBP1A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1027557"/>
<interactant intactId="EBI-779636">
<id>P01137</id>
<label>TGFB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1027557"/>
<interactant intactId="EBI-347088">
<id>P63104</id>
<label>YWHAZ</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="39 46">Cell membrane</location>
<topology evidence="46">Single-pass type I membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="24">Cell junction</location>
<location evidence="24">Tight junction</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="39">Cell surface</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="39">Membrane raft</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P36897-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P36897-2</id>
<name>2</name>
<name>B</name>
<sequence type="described" ref="VSP_041326"/>
</isoform>
<isoform>
<id>P36897-3</id>
<name>3</name>
<sequence type="described" ref="VSP_041327"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="39">Found in all tissues examined, most abundant in placenta and least abundant in brain and heart. Expressed in a variety of cancer cell lines (PubMed:25893292).</text>
</comment>
<comment type="PTM">
<text evidence="18 40">Phosphorylated at basal levels in the absence of ligand. Activated upon phosphorylation by TGFBR2, mainly in the GS domain. Phosphorylation in the GS domain abrogates FKBP1A-binding.</text>
</comment>
<comment type="PTM">
<text evidence="47">N-Glycosylated.</text>
</comment>
<comment type="PTM">
<text evidence="22 38 39">Ubiquitinated; undergoes ubiquitination catalyzed by several E3 ubiquitin ligases including SMURF1, SMURF2 and NEDD4L2. Results in the proteasomal and/or lysosomal degradation of the receptor thereby negatively regulating its activity. Deubiquitinated by USP15, leading to stabilization of the protein and enhanced TGF-beta signal. Its ubiquitination and proteasome-mediated degradation is negatively regulated by SDCBP (PubMed:25893292).</text>
</comment>
<comment type="disease" evidence="23 25 27 28 34 37">
<disease id="DI-00675">
<name>Loeys-Dietz syndrome 1</name>
<acronym>LDS1</acronym>
<description>An aortic aneurysm syndrome with widespread systemic involvement, characterized by arterial tortuosity and aneurysms, hypertelorism, and bifid uvula or cleft palate. Physical findings include prominent joint laxity, easy bruising, wide and atrophic scars, velvety and translucent skin with easily visible veins, spontaneous rupture of the spleen or bowel, and catastrophic complications of pregnancy, including rupture of the gravid uterus and the arteries, either during pregnancy or in the immediate postpartum period. Some patients have craniosynostosis, exotropy, micrognathia and retrognathia, structural brain abnormalities, and intellectual deficit.</description>
<dbReference type="MIM" id="609192"/>
</disease>
<text evidence="27">The disease is caused by mutations affecting the gene represented in this entry. TGFBR1 mutation Gln-487 has been reported to be associated with thoracic aortic aneurysms and dissection (TAAD) (PubMed:16791849). This phenotype, also known as thoracic aortic aneurysms type 5 (AAT5), is distinguised from LDS1 by having aneurysms restricted to thoracic aorta. It is unclear, however, if this condition is fulfilled in individuals bearing Gln-487 mutation, that is why they are considered as LDS1 by the OMIM resource.</text>
</comment>
<comment type="disease" evidence="36">
<disease id="DI-03159">
<name>Multiple self-healing squamous epithelioma</name>
<acronym>MSSE</acronym>
<description>A disorder characterized by multiple skin tumors that undergo spontaneous regression. Tumors appear most often on sun-exposed regions, are locally invasive, and undergo spontaneous resolution over a period of months leaving pitted scars.</description>
<dbReference type="MIM" id="132800"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="52">Belongs to the protein kinase superfamily. TKL Ser/Thr protein kinase family. TGFB receptor subfamily.</text>
</comment>
<comment type="caution">
<text evidence="37 49">One report originally reported variant Ile-375 (PubMed:22113417). This variant has been subsequently corrected to Arg-375 by the same authors (Ref.48).</text>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/tgfbr1/"/>
</comment>
<dbReference type="EC" id="2.7.11.30"/>
<dbReference type="EMBL" id="L11695">
<property type="protein sequence ID" value="AAA16073.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF054598">
<property type="protein sequence ID" value="AAC08998.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF054590">
<property type="protein sequence ID" value="AAC08998.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF054591">
<property type="protein sequence ID" value="AAC08998.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF054592">
<property type="protein sequence ID" value="AAC08998.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF054593">
<property type="protein sequence ID" value="AAC08998.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF054594">
<property type="protein sequence ID" value="AAC08998.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF054595">
<property type="protein sequence ID" value="AAC08998.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF054596">
<property type="protein sequence ID" value="AAC08998.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF054597">
<property type="protein sequence ID" value="AAC08998.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF035670">
<property type="protein sequence ID" value="AAD02042.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF035662">
<property type="protein sequence ID" value="AAD02042.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF035663">
<property type="protein sequence ID" value="AAD02042.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF035664">
<property type="protein sequence ID" value="AAD02042.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF035665">
<property type="protein sequence ID" value="AAD02042.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF035666">
<property type="protein sequence ID" value="AAD02042.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF035667">
<property type="protein sequence ID" value="AAD02042.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF035668">
<property type="protein sequence ID" value="AAD02042.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF035669">
<property type="protein sequence ID" value="AAD02042.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AY497473">
<property type="protein sequence ID" value="AAR32097.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL162427">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC071181">
<property type="protein sequence ID" value="AAH71181.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ619019">
<property type="protein sequence ID" value="CAF02096.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ619020">
<property type="protein sequence ID" value="CAF02097.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS47998.1">
<molecule id="P36897-3"/>
</dbReference>
<dbReference type="CCDS" id="CCDS6738.1">
<molecule id="P36897-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS78413.1">
<molecule id="P36897-2"/>
</dbReference>
<dbReference type="PIR" id="A49432">
<property type="entry name" value="A49432"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001124388.1">
<molecule id="P36897-3"/>
<property type="nucleotide sequence ID" value="NM_001130916.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001293139.1">
<molecule id="P36897-2"/>
<property type="nucleotide sequence ID" value="NM_001306210.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_004603.1">
<molecule id="P36897-1"/>
<property type="nucleotide sequence ID" value="NM_004612.3"/>
</dbReference>
<dbReference type="UniGene" id="Hs.494622"/>
<dbReference type="PDB" id="1B6C">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="B/D/F/H=162-503"/>
</dbReference>
<dbReference type="PDB" id="1IAS">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A/B/C/D/E=162-503"/>
</dbReference>
<dbReference type="PDB" id="1PY5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=175-500"/>
</dbReference>
<dbReference type="PDB" id="1RW8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=200-500"/>
</dbReference>
<dbReference type="PDB" id="1TBI">
<property type="method" value="Model"/>
<property type="chains" value="A=34-114"/>
</dbReference>
<dbReference type="PDB" id="1VJY">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=201-503"/>
</dbReference>
<dbReference type="PDB" id="2L5S">
<property type="method" value="NMR"/>
<property type="chains" value="A=31-115"/>
</dbReference>
<dbReference type="PDB" id="2PJY">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="C=33-111"/>
</dbReference>
<dbReference type="PDB" id="2WOT">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.85"/>
<property type="chains" value="A=200-503"/>
</dbReference>
<dbReference type="PDB" id="2WOU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=200-503"/>
</dbReference>
<dbReference type="PDB" id="2X7O">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.70"/>
<property type="chains" value="A/B/C/D/E=162-503"/>
</dbReference>
<dbReference type="PDB" id="3FAA">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.35"/>
<property type="chains" value="A/B/C/D/E=162-503"/>
</dbReference>
<dbReference type="PDB" id="3GXL">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=201-503"/>
</dbReference>
<dbReference type="PDB" id="3HMM">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=201-503"/>
</dbReference>
<dbReference type="PDB" id="3KCF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/B/C/D/E=162-503"/>
</dbReference>
<dbReference type="PDB" id="3KFD">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="I/J/K/L=31-115"/>
</dbReference>
<dbReference type="PDB" id="3TZM">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=200-503"/>
</dbReference>
<dbReference type="PDB" id="4X0M">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.68"/>
<property type="chains" value="A=200-503"/>
</dbReference>
<dbReference type="PDB" id="4X2F">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.49"/>
<property type="chains" value="A=200-503"/>
</dbReference>
<dbReference type="PDB" id="4X2G">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.51"/>
<property type="chains" value="A=200-503"/>
</dbReference>
<dbReference type="PDB" id="4X2J">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.69"/>
<property type="chains" value="A=200-503"/>
</dbReference>
<dbReference type="PDB" id="4X2K">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.69"/>
<property type="chains" value="A=200-503"/>
</dbReference>
<dbReference type="PDB" id="4X2N">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=200-503"/>
</dbReference>
<dbReference type="PDB" id="5E8S">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.45"/>
<property type="chains" value="A=200-503"/>
</dbReference>
<dbReference type="PDB" id="5E8T">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=200-503"/>
</dbReference>
<dbReference type="PDB" id="5E8U">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.03"/>
<property type="chains" value="A=200-503"/>
</dbReference>
<dbReference type="PDB" id="5E8W">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.86"/>
<property type="chains" value="A=200-503"/>
</dbReference>
<dbReference type="PDB" id="5E8X">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.45"/>
<property type="chains" value="A=200-503"/>
</dbReference>
<dbReference type="PDB" id="5E8Z">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.51"/>
<property type="chains" value="A=200-503"/>
</dbReference>
<dbReference type="PDB" id="5E90">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.05"/>
<property type="chains" value="A=200-503"/>
</dbReference>
<dbReference type="PDB" id="5FRI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=200-498"/>
</dbReference>
<dbReference type="PDBsum" id="1B6C"/>
<dbReference type="PDBsum" id="1IAS"/>
<dbReference type="PDBsum" id="1PY5"/>
<dbReference type="PDBsum" id="1RW8"/>
<dbReference type="PDBsum" id="1TBI"/>
<dbReference type="PDBsum" id="1VJY"/>
<dbReference type="PDBsum" id="2L5S"/>
<dbReference type="PDBsum" id="2PJY"/>
<dbReference type="PDBsum" id="2WOT"/>
<dbReference type="PDBsum" id="2WOU"/>
<dbReference type="PDBsum" id="2X7O"/>
<dbReference type="PDBsum" id="3FAA"/>
<dbReference type="PDBsum" id="3GXL"/>
<dbReference type="PDBsum" id="3HMM"/>
<dbReference type="PDBsum" id="3KCF"/>
<dbReference type="PDBsum" id="3KFD"/>
<dbReference type="PDBsum" id="3TZM"/>
<dbReference type="PDBsum" id="4X0M"/>
<dbReference type="PDBsum" id="4X2F"/>
<dbReference type="PDBsum" id="4X2G"/>
<dbReference type="PDBsum" id="4X2J"/>
<dbReference type="PDBsum" id="4X2K"/>
<dbReference type="PDBsum" id="4X2N"/>
<dbReference type="PDBsum" id="5E8S"/>
<dbReference type="PDBsum" id="5E8T"/>
<dbReference type="PDBsum" id="5E8U"/>
<dbReference type="PDBsum" id="5E8W"/>
<dbReference type="PDBsum" id="5E8X"/>
<dbReference type="PDBsum" id="5E8Z"/>
<dbReference type="PDBsum" id="5E90"/>
<dbReference type="PDBsum" id="5FRI"/>
<dbReference type="ProteinModelPortal" id="P36897"/>
<dbReference type="SMR" id="P36897"/>
<dbReference type="BioGrid" id="112904">
<property type="interactions" value="182"/>
</dbReference>
<dbReference type="DIP" id="DIP-5935N"/>
<dbReference type="IntAct" id="P36897">
<property type="interactions" value="16"/>
</dbReference>
<dbReference type="MINT" id="MINT-152959"/>
<dbReference type="STRING" id="9606.ENSP00000364133"/>
<dbReference type="BindingDB" id="P36897"/>
<dbReference type="ChEMBL" id="CHEMBL4439"/>
<dbReference type="DrugBank" id="DB07267">
<property type="generic name" value="2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine"/>
</dbReference>
<dbReference type="DrugBank" id="DB03921">
<property type="generic name" value="4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline"/>
</dbReference>
<dbReference type="DrugBank" id="DB08450">
<property type="generic name" value="N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine"/>
</dbReference>
<dbReference type="DrugBank" id="DB07152">
<property type="generic name" value="N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide"/>
</dbReference>
<dbReference type="DrugBank" id="DB04434">
<property type="generic name" value="Naphthyridine Inhibitor"/>
</dbReference>
<dbReference type="GuidetoPHARMACOLOGY" id="1788"/>
<dbReference type="iPTMnet" id="P36897"/>
<dbReference type="PhosphoSitePlus" id="P36897"/>
<dbReference type="BioMuta" id="TGFBR1"/>
<dbReference type="DMDM" id="547777"/>
<dbReference type="EPD" id="P36897"/>
<dbReference type="PaxDb" id="P36897"/>
<dbReference type="PeptideAtlas" id="P36897"/>
<dbReference type="PRIDE" id="P36897"/>
<dbReference type="DNASU" id="7046"/>
<dbReference type="Ensembl" id="ENST00000374990">
<molecule id="P36897-3"/>
<property type="protein sequence ID" value="ENSP00000364129"/>
<property type="gene ID" value="ENSG00000106799"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000374994">
<molecule id="P36897-1"/>
<property type="protein sequence ID" value="ENSP00000364133"/>
<property type="gene ID" value="ENSG00000106799"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000552516">
<molecule id="P36897-2"/>
<property type="protein sequence ID" value="ENSP00000447297"/>
<property type="gene ID" value="ENSG00000106799"/>
</dbReference>
<dbReference type="GeneID" id="7046"/>
<dbReference type="KEGG" id="hsa:7046"/>
<dbReference type="UCSC" id="uc004azd.4">
<molecule id="P36897-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="7046"/>
<dbReference type="DisGeNET" id="7046"/>
<dbReference type="GeneCards" id="TGFBR1"/>
<dbReference type="GeneReviews" id="TGFBR1"/>
<dbReference type="HGNC" id="HGNC:11772">
<property type="gene designation" value="TGFBR1"/>
</dbReference>
<dbReference type="HPA" id="CAB002441"/>
<dbReference type="HPA" id="CAB031481"/>
<dbReference type="HPA" id="HPA056473"/>
<dbReference type="MalaCards" id="TGFBR1"/>
<dbReference type="MIM" id="132800">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="190181">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="609192">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P36897"/>
<dbReference type="OpenTargets" id="ENSG00000106799"/>
<dbReference type="Orphanet" id="91387">
<property type="disease" value="Familial thoracic aortic aneurysm and aortic dissection"/>
</dbReference>
<dbReference type="Orphanet" id="60030">
<property type="disease" value="Loeys-Dietz syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="65748">
<property type="disease" value="Multiple keratoacanthoma, Ferguson-Smith type"/>
</dbReference>
<dbReference type="PharmGKB" id="PA36485"/>
<dbReference type="eggNOG" id="KOG2052">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XQT0">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000118876"/>
<dbReference type="HOGENOM" id="HOG000230587"/>
<dbReference type="HOVERGEN" id="HBG054502"/>
<dbReference type="InParanoid" id="P36897"/>
<dbReference type="KO" id="K04674"/>
<dbReference type="OMA" id="GATALQC"/>
<dbReference type="OrthoDB" id="EOG091G0BIU"/>
<dbReference type="PhylomeDB" id="P36897"/>
<dbReference type="TreeFam" id="TF314724"/>
<dbReference type="BRENDA" id="2.7.10.2">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="BRENDA" id="2.7.11.30">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2173788">
<property type="pathway name" value="Downregulation of TGF-beta receptor signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2173789">
<property type="pathway name" value="TGF-beta receptor signaling activates SMADs"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2173791">
<property type="pathway name" value="TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3304356">
<property type="pathway name" value="SMAD2/3 Phosphorylation Motif Mutants in Cancer"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3315487">
<property type="pathway name" value="SMAD2/3 MH2 Domain Mutants in Cancer"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3645790">
<property type="pathway name" value="TGFBR2 Kinase Domain Mutants in Cancer"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3656532">
<property type="pathway name" value="TGFBR1 KD Mutants in Cancer"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3656535">
<property type="pathway name" value="TGFBR1 LBD Mutants in Cancer"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5689603">
<property type="pathway name" value="UCH proteinases"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5689880">
<property type="pathway name" value="Ub-specific processing proteases"/>
</dbReference>
<dbReference type="SignaLink" id="P36897"/>
<dbReference type="SIGNOR" id="P36897"/>
<dbReference type="ChiTaRS" id="TGFBR1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P36897"/>
<dbReference type="GeneWiki" id="TGF_beta_receptor_1"/>
<dbReference type="GenomeRNAi" id="7046"/>
<dbReference type="PRO" id="PR:P36897"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 9"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000106799"/>
<dbReference type="CleanEx" id="HS_TGFBR1"/>
<dbReference type="ExpressionAtlas" id="P36897">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P36897">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005923">
<property type="term" value="C:bicellular tight junction"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005623">
<property type="term" value="C:cell"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0009986">
<property type="term" value="C:cell surface"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005768">
<property type="term" value="C:endosome"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005622">
<property type="term" value="C:intracellular"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="GOC"/>
</dbReference>
<dbReference type="GO" id="GO:0043231">
<property type="term" value="C:intracellular membrane-bounded organelle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0045121">
<property type="term" value="C:membrane raft"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043235">
<property type="term" value="C:receptor complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070022">
<property type="term" value="C:transforming growth factor beta receptor complex"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HGNC"/>
</dbReference>
<dbReference type="GO" id="GO:0070411">
<property type="term" value="F:I-SMAD binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0004672">
<property type="term" value="F:protein kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0004674">
<property type="term" value="F:protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HGNC"/>
</dbReference>
<dbReference type="GO" id="GO:0005057">
<property type="term" value="F:signal transducer activity, downstream of receptor"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0004702">
<property type="term" value="F:signal transducer, downstream of receptor, with serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046332">
<property type="term" value="F:SMAD binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HGNC"/>
</dbReference>
<dbReference type="GO" id="GO:0050431">
<property type="term" value="F:transforming growth factor beta binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005025">
<property type="term" value="F:transforming growth factor beta receptor activity, type I"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005024">
<property type="term" value="F:transforming growth factor beta-activated receptor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005114">
<property type="term" value="F:type II transforming growth factor beta receptor binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000186">
<property type="term" value="P:activation of MAPKK activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0032924">
<property type="term" value="P:activin receptor signaling pathway"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0060978">
<property type="term" value="P:angiogenesis involved in coronary vascular morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0009952">
<property type="term" value="P:anterior/posterior pattern specification"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006915">
<property type="term" value="P:apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0048844">
<property type="term" value="P:artery morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001824">
<property type="term" value="P:blastocyst development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0060317">
<property type="term" value="P:cardiac epithelial to mesenchymal transition"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0007050">
<property type="term" value="P:cell cycle arrest"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048870">
<property type="term" value="P:cell motility"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0071560">
<property type="term" value="P:cellular response to transforming growth factor beta stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030199">
<property type="term" value="P:collagen fibril organization"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060982">
<property type="term" value="P:coronary artery morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0048701">
<property type="term" value="P:embryonic cranial skeleton morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042118">
<property type="term" value="P:endothelial cell activation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0043542">
<property type="term" value="P:endothelial cell migration"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1905223">
<property type="term" value="P:epicardium morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001837">
<property type="term" value="P:epithelial to mesenchymal transition"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043062">
<property type="term" value="P:extracellular structure organization"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008354">
<property type="term" value="P:germ cell migration"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007507">
<property type="term" value="P:heart development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0001701">
<property type="term" value="P:in utero embryonic development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0035556">
<property type="term" value="P:intracellular signal transduction"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0001822">
<property type="term" value="P:kidney development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0002088">
<property type="term" value="P:lens development in camera-type eye"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008584">
<property type="term" value="P:male gonad development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0048762">
<property type="term" value="P:mesenchymal cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0032331">
<property type="term" value="P:negative regulation of chondrocyte differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001937">
<property type="term" value="P:negative regulation of endothelial cell proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:2001237">
<property type="term" value="P:negative regulation of extrinsic apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030512">
<property type="term" value="P:negative regulation of transforming growth factor beta receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0048663">
<property type="term" value="P:neuron fate commitment"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060021">
<property type="term" value="P:palate development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060017">
<property type="term" value="P:parathyroid gland development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060389">
<property type="term" value="P:pathway-restricted SMAD protein phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0018105">
<property type="term" value="P:peptidyl-serine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0018107">
<property type="term" value="P:peptidyl-threonine phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060037">
<property type="term" value="P:pharyngeal system development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2001235">
<property type="term" value="P:positive regulation of apoptotic signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030307">
<property type="term" value="P:positive regulation of cell growth"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030335">
<property type="term" value="P:positive regulation of cell migration"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008284">
<property type="term" value="P:positive regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="HGNC"/>
</dbReference>
<dbReference type="GO" id="GO:0051272">
<property type="term" value="P:positive regulation of cellular component movement"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0001938">
<property type="term" value="P:positive regulation of endothelial cell proliferation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0010718">
<property type="term" value="P:positive regulation of epithelial to mesenchymal transition"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1905007">
<property type="term" value="P:positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051491">
<property type="term" value="P:positive regulation of filopodium assembly"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0010628">
<property type="term" value="P:positive regulation of gene expression"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:1905075">
<property type="term" value="P:positive regulation of occluding junction disassembly"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010862">
<property type="term" value="P:positive regulation of pathway-restricted SMAD protein phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051897">
<property type="term" value="P:positive regulation of protein kinase B signaling"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060391">
<property type="term" value="P:positive regulation of SMAD protein import into nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051496">
<property type="term" value="P:positive regulation of stress fiber assembly"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045893">
<property type="term" value="P:positive regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0009791">
<property type="term" value="P:post-embryonic development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016579">
<property type="term" value="P:protein deubiquitination"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060043">
<property type="term" value="P:regulation of cardiac muscle cell proliferation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010717">
<property type="term" value="P:regulation of epithelial to mesenchymal transition"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0010468">
<property type="term" value="P:regulation of gene expression"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0043393">
<property type="term" value="P:regulation of protein binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031396">
<property type="term" value="P:regulation of protein ubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006355">
<property type="term" value="P:regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HGNC"/>
</dbReference>
<dbReference type="GO" id="GO:0070723">
<property type="term" value="P:response to cholesterol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007165">
<property type="term" value="P:signal transduction"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HGNC"/>
</dbReference>
<dbReference type="GO" id="GO:0001501">
<property type="term" value="P:skeletal system development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0048705">
<property type="term" value="P:skeletal system morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0048538">
<property type="term" value="P:thymus development"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0007179">
<property type="term" value="P:transforming growth factor beta receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003223">
<property type="term" value="P:ventricular compact myocardium morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060412">
<property type="term" value="P:ventricular septum morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0003222">
<property type="term" value="P:ventricular trabecula myocardium morphogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042060">
<property type="term" value="P:wound healing"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="InterPro" id="IPR000472">
<property type="entry name" value="Activin_recp"/>
</dbReference>
<dbReference type="InterPro" id="IPR003605">
<property type="entry name" value="GS_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR008271">
<property type="entry name" value="Ser/Thr_kinase_AS"/>
</dbReference>
<dbReference type="InterPro" id="IPR000333">
<property type="entry name" value="TGFB_receptor"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR23255">
<property type="entry name" value="PTHR23255"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01064">
<property type="entry name" value="Activin_recp"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00069">
<property type="entry name" value="Pkinase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF08515">
<property type="entry name" value="TGF_beta_GS"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00467">
<property type="entry name" value="GS"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00220">
<property type="entry name" value="S_TKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51256">
<property type="entry name" value="GS"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00108">
<property type="entry name" value="PROTEIN_KINASE_ST"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0993">Aortic aneurysm</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0965">Cell junction</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0989">Craniosynostosis</keyword>
<keyword id="KW-0221">Differentiation</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0341">Growth regulation</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0460">Magnesium</keyword>
<keyword id="KW-0464">Manganese</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0796">Tight junction</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="signal peptide" evidence="47">
<location>
<begin position="1"/>
<end position="33"/>
</location>
</feature>
<feature type="chain" description="TGF-beta receptor type-1" id="PRO_0000024423">
<location>
<begin position="34"/>
<end position="503"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="11">
<location>
<begin position="34"/>
<end position="126"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical" evidence="11">
<location>
<begin position="127"/>
<end position="147"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="11">
<location>
<begin position="148"/>
<end position="503"/>
</location>
</feature>
<feature type="domain" description="GS" evidence="13">
<location>
<begin position="175"/>
<end position="204"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="12">
<location>
<begin position="205"/>
<end position="495"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="12">
<location>
<begin position="211"/>
<end position="219"/>
</location>
</feature>
<feature type="short sequence motif" description="FKBP1A-binding">
<location>
<begin position="193"/>
<end position="194"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="12 14">
<location>
<position position="333"/>
</location>
</feature>
<feature type="binding site" description="ATP" evidence="12">
<location>
<position position="232"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="9">
<location>
<position position="165"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by TGFBR2" evidence="40">
<location>
<position position="185"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by TGFBR2" evidence="40">
<location>
<position position="186"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by TGFBR2" evidence="40">
<location>
<position position="187"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by TGFBR2" evidence="40">
<location>
<position position="189"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by TGFBR2" evidence="40">
<location>
<position position="191"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="11">
<location>
<position position="45"/>
</location>
</feature>
<feature type="disulfide bond" evidence="31 35">
<location>
<begin position="36"/>
<end position="54"/>
</location>
</feature>
<feature type="disulfide bond" evidence="31 35">
<location>
<begin position="38"/>
<end position="41"/>
</location>
</feature>
<feature type="disulfide bond" evidence="31 35">
<location>
<begin position="48"/>
<end position="71"/>
</location>
</feature>
<feature type="disulfide bond" evidence="31 35">
<location>
<begin position="86"/>
<end position="100"/>
</location>
</feature>
<feature type="disulfide bond" evidence="31 35">
<location>
<begin position="101"/>
<end position="106"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)" evidence="10">
<location>
<position position="391"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_041326" evidence="51">
<original>T</original>
<variation>TGPFS</variation>
<location>
<position position="114"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_041327" evidence="50">
<location>
<begin position="115"/>
<end position="191"/>
</location>
</feature>
<feature type="sequence variant" description="In allele TGFBR1*6A; could be a tumor susceptibility allele." id="VAR_022342">
<location>
<begin position="24"/>
<end position="26"/>
</location>
</feature>
<feature type="sequence variant" description="In allele TGFBR1*10A; rare polymorphism." id="VAR_022343" evidence="47">
<original>A</original>
<variation>AA</variation>
<location>
<position position="26"/>
</location>
</feature>
<feature type="sequence variant" description="In MSSE; hypomorphic mutation." id="VAR_065826" evidence="36">
<original>C</original>
<variation>Y</variation>
<location>
<position position="41"/>
</location>
</feature>
<feature type="sequence variant" description="In MSSE; hypomorphic mutation; dbSNP:rs387906696." id="VAR_065827" evidence="36">
<original>N</original>
<variation>S</variation>
<location>
<position position="45"/>
</location>
</feature>
<feature type="sequence variant" description="In MSSE; hypomorphic mutation; dbSNP:rs587776865." id="VAR_065828" evidence="36">
<original>G</original>
<variation>R</variation>
<location>
<position position="52"/>
</location>
</feature>
<feature type="sequence variant" description="In MSSE; hypomorphic mutation; dbSNP:rs757374917." id="VAR_065829" evidence="36">
<original>P</original>
<variation>L</variation>
<location>
<position position="83"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs148176750." id="VAR_054160" evidence="33">
<original>I</original>
<variation>V</variation>
<location>
<position position="139"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56014374." id="VAR_041412" evidence="30">
<original>V</original>
<variation>I</variation>
<location>
<position position="153"/>
</location>
</feature>
<feature type="sequence variant" description="In LDS1; dbSNP:rs121918712." id="VAR_022344" evidence="23">
<original>T</original>
<variation>I</variation>
<location>
<position position="200"/>
</location>
</feature>
<feature type="sequence variant" description="In LDS1." id="VAR_029481" evidence="28">
<original>K</original>
<variation>E</variation>
<location>
<position position="232"/>
</location>
</feature>
<feature type="sequence variant" description="In LDS1; dbSNP:rs111854391." id="VAR_029482" evidence="25 27">
<original>S</original>
<variation>L</variation>
<location>
<position position="241"/>
</location>
</feature>
<feature type="sequence variant" description="In LDS1." id="VAR_066720" evidence="37">
<original>D</original>
<variation>Y</variation>
<location>
<position position="266"/>
</location>
</feature>
<feature type="sequence variant" description="In a patient with Marfan syndrome." id="VAR_029483" evidence="27">
<original>N</original>
<variation>H</variation>
<location>
<position position="267"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35974499." id="VAR_041413" evidence="30">
<original>Y</original>
<variation>C</variation>
<location>
<position position="291"/>
</location>
</feature>
<feature type="sequence variant" description="In LDS1; dbSNP:rs121918710." id="VAR_022345" evidence="23">
<original>M</original>
<variation>R</variation>
<location>
<position position="318"/>
</location>
</feature>
<feature type="sequence variant" description="In LDS1." id="VAR_066721" evidence="34">
<original>D</original>
<variation>G</variation>
<location>
<position position="351"/>
</location>
</feature>
<feature type="sequence variant" description="In LDS1." id="VAR_066722" evidence="37">
<original>T</original>
<variation>R</variation>
<location>
<position position="375"/>
</location>
</feature>
<feature type="sequence variant" description="In LDS1; dbSNP:rs121918711." id="VAR_022346" evidence="23">
<original>D</original>
<variation>G</variation>
<location>
<position position="400"/>
</location>
</feature>
<feature type="sequence variant" description="In LDS1; dbSNP:rs113605875." id="VAR_022347" evidence="23 28">
<original>R</original>
<variation>P</variation>
<location>
<position position="487"/>
</location>
</feature>
<feature type="sequence variant" description="In LDS1; dbSNP:rs113605875." id="VAR_029484" evidence="27 28 37">
<original>R</original>
<variation>Q</variation>
<location>
<position position="487"/>
</location>
</feature>
<feature type="sequence variant" description="In LDS1; dbSNP:rs111426349." id="VAR_029485" evidence="28">
<original>R</original>
<variation>W</variation>
<location>
<position position="487"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of phosphorylation on threonine residues. Loss of threonine phosphorylation, reduced phosphorylation on serine residues and loss of response to TGF-beta; when associated with A-187; A-189 and A-191." evidence="40">
<original>TT</original>
<variation>VV</variation>
<location>
<begin position="185"/>
<end position="186"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of threonine phosphorylation, reduced phosphorylation on serine residues and loss of response to TGF-beta; when associated with 185-VV-186; A-189 and A-191." evidence="40">
<original>S</original>
<variation>A</variation>
<location>
<position position="187"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of threonine phosphorylation, reduced phosphorylation on serine residues and loss of response to TGF-beta; when associated with 185-VV-186; A-187 and A-191." evidence="40">
<original>S</original>
<variation>A</variation>
<location>
<position position="189"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of threonine phosphorylation, reduced phosphorylation on serine residues and loss of response to TGF-beta; when associated with 185-VV-186; A-187 and A-189." evidence="40">
<original>S</original>
<variation>A</variation>
<location>
<position position="191"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with FKBP1A." evidence="43">
<original>L</original>
<variation>G</variation>
<location>
<position position="193"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of interaction with FKBP1A." evidence="43">
<original>P</original>
<variation>K</variation>
<location>
<position position="194"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of response to TGF-beta." evidence="40">
<original>T</original>
<variation>D</variation>
<location>
<position position="200"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of phosphorylation. Loss of response to TGF-beta." evidence="40">
<original>T</original>
<variation>V</variation>
<location>
<position position="200"/>
</location>
</feature>
<feature type="mutagenesis site" description="Constitutive activation." evidence="40">
<original>T</original>
<variation>D</variation>
<location>
<position position="204"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced phosphorylation. Reduced response to TGF-beta." evidence="40">
<original>T</original>
<variation>V</variation>
<location>
<position position="204"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="35"/>
<end position="37"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="42"/>
<end position="46"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="51"/>
<end position="57"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="61"/>
<end position="63"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="69"/>
<end position="72"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="74"/>
<end position="76"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="77"/>
<end position="82"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="84"/>
<end position="86"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="89"/>
<end position="92"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="94"/>
<end position="101"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="102"/>
<end position="105"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="107"/>
<end position="109"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="177"/>
<end position="183"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="187"/>
<end position="190"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="191"/>
<end position="193"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="202"/>
<end position="204"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="205"/>
<end position="213"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="215"/>
<end position="224"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="227"/>
<end position="234"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="236"/>
<end position="238"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="239"/>
<end position="249"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="251"/>
<end position="253"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="262"/>
<end position="269"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="271"/>
<end position="281"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="288"/>
<end position="294"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="299"/>
<end position="317"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="322"/>
<end position="324"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="328"/>
<end position="330"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="336"/>
<end position="338"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="339"/>
<end position="341"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="347"/>
<end position="349"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="352"/>
<end position="354"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="356"/>
<end position="359"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="360"/>
<end position="363"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="364"/>
<end position="367"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="368"/>
<end position="371"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="376"/>
<end position="378"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="381"/>
<end position="384"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="393"/>
<end position="413"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="417"/>
<end position="419"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="427"/>
<end position="431"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="438"/>
<end position="445"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="456"/>
<end position="460"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="462"/>
<end position="474"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="479"/>
<end position="481"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="485"/>
<end position="497"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1B6C"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2L5S"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2PJY"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3KCF"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3KFD"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5E8S"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5E8X"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5E8Z"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19369195"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000250"/>
<evidence key="11" type="ECO:0000255"/>
<evidence key="12" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00585"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10027"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10025408"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11163210"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11278251"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11583628"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12941698"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15177479"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15317461"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15496141"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15731757"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15761148"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16596670"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16754747"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16791849"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16928994"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17099224"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18243111"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18758450"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18987736"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19883511"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20207738"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21358634"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22113417"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22344298"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25893292"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7774578"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8752209"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8980228"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9233797"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9311995"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9346908"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9472030"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9661882"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9865696"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source ref="48"/>
</evidence>
<evidence key="50" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="17845732"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000305"/>
<sequence length="503" mass="55960" checksum="179F11404725DDCB" modified="1994-06-01" version="1" precursor="true">
MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTE
TTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPG
LGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDL
IYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREER
SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVE
GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS
ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI
HEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGA
ARLTALRIKKTLSQLSQQEGIKM
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>